Xpert® Tropical Fever Test on GeneXpert® Edge X System

NCT07520279 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2026-04-09

No results posted yet for this study

Summary

This is a multi-site, observational, cross-sectional clinical study that includes geographically diverse sites within and outside the United States.

Conditions

  • Malaria Fever
  • Zika
  • Dengue Fever
  • Leptospirosis
  • Chikungunya Virus Infection

Interventions

DIAGNOSTIC_TEST

Xpert Tropical Fever test

Detection and identification of nucleic acids from multiple fever-causing pathogens.

Sponsors & Collaborators

  • Cepheid

    lead INDUSTRY

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-18
Primary Completion
2026-08-31
Completion
2027-02-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07520279 on ClinicalTrials.gov